Abstract

Ventilator-associated pneumonia (VAP) is a common cause of morbidity, antibiotic use, increased length of stay and, possibly, increased mortality in ICU patients. Colonization of the oropharyngeal cavity with potentially pathogenic micro-organisms is instrumental in the pathogenesis of VAP, and selective oropharyngeal decontamination (SOD) with antibiotics (AB-SOD) or antiseptics, such as chlorhexidine gluconate (CHX-SOD), has been associated with reduced incidences of VAP. In a recent issue of Critical Care Scannapieco and colleagues investigated differences in oropharyngeal colonization between mechanically ventilated patients receiving oropharyngeal decontamination with 0.12% CHX-SOD either once or twice daily compared to placebo. CHX-SOD was associated with a reduction in Staphylococcus aureus colonization, but the study was underpowered to demonstrate a reduction in VAP incidence. We urgently need well-designed and adequately powered studies to evaluate the potential benefits of CHX-SOD on patient outcome in ICUs.

Highlights

  • AB-selective oropharyngeal decontamination (SOD) was associated with reduced incidences of Ventilator-associated pneumonia (VAP) in various studies [4-6], and recently with a better 28-day survival in a large Dutch multi-center study [7]

  • AB-SOD was associated with reduced incidences of VAP in various studies [4-6], and recently with a better 28-day survival in a large Dutch multi-center study [7]

  • AB-SOD was effective in improving patient outcome as selective decontamination of the digestive tract (SDD), which combines AB-SOD with intestinal decontamination and 4 days of intravenous cefotaxim

Read more

Summary

Introduction

AB-SOD was associated with reduced incidences of VAP in various studies [4-6], and recently with a better 28-day survival in a large Dutch multi-center study [7]. Oropharyngeal decontamination with antibiotics (AB-SOD)) or with topically applied chlorhexidine gluconate (CHX-SOD). Replacing antibiotics with antiseptics for oral decontamination might offer an effective and safe measure for ICU patients, even in settings with high levels of AMRB.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call